We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+2.78%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$25.3B
AUM Growth
+$3.35B
Cap. Flow
+$3.04B
Cap. Flow %
12.05%
Top 10 Hldgs %
37.53%
Holding
89
New
10
Increased
31
Reduced
27
Closed
8

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.01B
2
LH icon
Labcorp
LH
+$483M
3
MAN icon
ManpowerGroup
MAN
+$325M
4
BKNG icon
Booking.com
BKNG
+$318M
5
TMO icon
Thermo Fisher Scientific
TMO
+$306M

Sector Composition

Rank Sector Weight
1 Healthcare 40.7%
2 Consumer Discretionary 11.23%
3 Technology 9.51%
4 Industrials 8.66%
5 Materials 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUM icon
1
Humana
HUM
$43.5B
$1.26B 4.97%
6,566,967
+1,550,431
+31% +$288M
TMO icon
2
Thermo Fisher Scientific
TMO
$216B
$1.2B 4.76%
9,259,710
+2,348,939
+34% +$306M
ABBV icon
3
AbbVie
ABBV
$434B
$1.2B 4.75%
17,855,941
+15,412,309
+631% +$1.01B
MON
4
DELISTED
Monsanto Co
MON
$1.18B 4.67%
11,073,137
+1,381,400
+14% +$160M
THC icon
5
Tenet Healthcare
THC
$20.7B
$856M 3.39%
14,792,313
+979,482
+7% +$50M
FLEX icon
6
Flex
FLEX
$40.4B
$850M 3.37%
99,698,783
CYH icon
7
Community Health Systems
CYH
$409M
$762M 3.02%
14,633,492
ELV icon
8
Elevance Health
ELV
$81.4B
$758M 3%
4,619,666
-273,934
-6% -$43.8M
AET
9
DELISTED
Aetna Inc
AET
$710M 2.81%
5,571,408
+2,044,083
+58% +$233M
ENDP
10
DELISTED
Endo International plc
ENDP
$704M 2.79%
8,837,703
+1,991,820
+29% +$172M
WOOF
11
DELISTED
VCA Inc.
WOOF
$696M 2.76%
12,800,370
PVH icon
12
PVH
PVH
$4.14B
$606M 2.4%
5,260,874
+345,251
+7% +$37.5M
AGN
13
DELISTED
Allergan plc
AGN
$602M 2.38%
1,982,709
MAN icon
14
ManpowerGroup
MAN
$2.54B
$540M 2.14%
6,038,795
+3,770,664
+166% +$325M
PARA
15
DELISTED
Paramount Global Class B
PARA
$485M 1.92%
8,731,715
+1,836,349
+27% +$111M
LH icon
16
Labcorp
LH
$25.2B
$483M 1.91%
+4,636,905
New +$483M
HCA icon
17
HCA Healthcare
HCA
$89.8B
$470M 1.86%
5,178,578
-100
-0% -$8.01K
CI icon
18
Cigna
CI
$73.5B
$457M 1.81%
2,821,469
+1,042,632
+59% +$144M
CDNS icon
19
Cadence Design Systems
CDNS
$91.8B
$452M 1.79%
23,013,908
AMAT icon
20
Applied Materials
AMAT
$393B
$409M 1.62%
21,275,054
+7,823,700
+58% +$161M
BKD icon
21
Brookdale Senior Living
BKD
$3.56B
$402M 1.59%
11,591,430
PNR icon
22
Pentair
PNR
$10.7B
$402M 1.59%
8,696,028
-1,784,799
-17% -$75.6M
DD icon
23
DuPont de Nemours
DD
$18.7B
$383M 1.52%
2,958,984
+541,245
+22% +$70.1M
CAR icon
24
Avis
CAR
$4.84B
$368M 1.46%
8,357,469
+1,264,445
+18% +$66.7M
SUNE
25
DELISTED
SUNEDISON, INC COM
SUNE
$341M 1.35%
11,403,277
-556,600
-5% -$15.9M

Similar funds

Glenview Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Glenview Capital Management held 89 positions worth $25.3B, up 15% from $21.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Glenview Capital Management deployed $3.04B of net new capital in Q2 2015, opening 10 new positions and adding to 31 existing holdings. Its largest new stake was Labcorp: 4,636,905 shares worth $483M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was eBay, an estimated $257M trimmed.

  • Glenview Capital Management's largest Q2 2015 buy was Labcorp: 4,636,905 shares worth $483M.
  • Glenview Capital Management added most to AbbVie in Q2 2015, an estimated $1.01B increase.
  • Glenview Capital Management's biggest Q2 2015 reduction was eBay, cutting an estimated $257M.
  • Glenview Capital Management fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2015, selling an estimated $490M.
  • Glenview Capital Management's ten largest holdings make up 38% of its $25.3B portfolio in Q2 2015.
  • Glenview Capital Management opened 10 new positions and closed 8 in Q2 2015.
  • Glenview Capital Management's portfolio value rose 15% quarter-over-quarter to $25.3B.

Based on Glenview Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.